Trial reportCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology2015
Impact of Risk Assessment and Tailored versus Nontailored Risk Information on Colorectal Cancer Testing in Primary Care: A Randomized Controlled Trial.
Trial report in Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 3 syntheses or guidelines pooled it.
- Personalizing cancer risk: a systematic review of risk communication strategies.Journal of cancer research and clinical oncology · 2026Pooled it
- Evaluation of Interventions Intended to Increase Colorectal Cancer Screening Rates in the United States: A Systematic Review and Meta-analysis.JAMA internal medicine · 2018Pooled it
- The effects of on-screen, point of care computer reminders on processes and outcomes of care.The Cochrane database of systematic reviews · 2009Pooled it
- Communicating risk to promote colorectal cancer screening: a multi-method study to test tailored versus targeted message strategies.Health education research · 2022Trial
- Effect of Patient-Directed Messaging on Colorectal Cancer Screening: A Randomized Clinical Trial.JAMA network open · 2022Trial
- Computer-tailored intervention increases colorectal cancer screening among low-income African Americans in primary care: Results of a randomized trial.Preventive medicine · 2021Trial
- Trial
- A scoping review of machine learning models to predict risk of falls in elders, without using sensor data.Diagnostic and prognostic research · 2025Review
- From English to "Englishes": A Process Perspective on Enhancing the Linguistic Responsiveness of Culturally Tailored Cancer Prevention Interventions.Journal of participatory medicine · 2024Article
- Physician preferences for an electronic lung cancer screening decision aid.The American journal of managed care · 2024Article
- Article
- Outcomes associated with use of thePreventive medicine reports · 2019Article
- Recommendation of colorectal cancer testing among primary care patients younger than 50 with elevated risk.Preventive medicine · 2017Article
- Barriers to Colorectal Cancer Screening in a Primary Care Setting in Turkey.Journal of community health · 2017Article
- Screening for colorectal cancer: the role of the primary care physician.European journal of gastroenterology & hepatology · 2017Review
- Tailored information increases patient/physician discussion of colon cancer risk and testing: The Cancer Risk Intake System trial.Preventive medicine reports · 2016Article
- Current use and costs of electronic health records for clinical trial research: a descriptive study.CMAJ openArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
backgroundColorectal cancer screening is effective but underused. Guidelines for which tests are recommended and at what intervals depend on specific risks. We developed a tablet-based Cancer Risk Intake System (CRIS) that asks questions about risk prior to appointments and generates tailored printouts for patients and physicians summarizing and matching risk factors with guideline-based recommendations.
methodsRandomized controlled trial among patients who: (i) used CRIS and they and their physicians received tailored printouts; (ii) used CRIS to answer questions but received standard information about cancer screening while their physicians received a standard electronic chart prompt indicating they were age-eligible but not currently adherent for colorectal cancer screening; or (iii) comprised a no-contact group that neither used CRIS nor received any information while their physicians received the standard prompt. Participation in testing was assessed via electronic medical record at 12 months.
resultsParticipation in any colorectal cancer testing was three times higher for those who used the CRIS and received any printed materials, compared with no-contact controls (47% vs. 16%; P < 0.0001). Among CRIS users ages 50 and older, participation in any testing was higher in the tailored group (53% vs. 44%, P = 0.023).
conclusionUse of CRIS and receipt of any information facilitated participation in testing. There was more testing participation in the CRIS-tailored than nontailored group. IMPACT: Asking patients questions about their specific risk factors and giving them and their providers information just prior to an appointment may increase participation in colorectal cancer testing. Tailoring the information has some added benefit.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.